US Stock MarketDetailed Quotes

MNKD MannKind

Watchlist
  • 5.030
  • 0.0000.00%
Close Mar 31 16:00 ET
  • 5.000
  • -0.030-0.60%
Post 20:01 ET
1.53BMarket Cap50.30P/E (TTM)

About MannKind Company

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Company Profile

SymbolMNKD
Company NameMannKind
Listing DateJul 28, 2004
Issue Price14.00
Founded1991
CEOMr. Michael E. Castagna, Pharm.D.
MarketNASDAQ
Employees407
Fiscal Year Ends12-31
Address1 Casper Street
CityDanbury
ProvinceConnecticut
CountryUnited States of America
Zip Code06810
Phone1-818-661-5000

Company Executives

  • Name
  • Position
  • Salary
  • Michael E. Castagna, Pharm.D.
  • Director and Chief Executive Officer
  • 7.07M
  • Christopher B. Prentiss
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Burkhard Blank,M.D.
  • Executive Vice President, Research and Development and Chief Medical Officer
  • --
  • Lauren M. Sabella
  • Executive Vice President, Operations
  • 1.91M
  • Sanjay R. Singh
  • Executive Vice President, Technical Operations
  • --
  • Dr. Stuart A. Tross, PhD
  • Executive Vice President, Human Resources
  • 2.22M
  • Dominic Marasco
  • President, Endocrine Business Unit
  • --
  • Dr. James S. Shannon, M.D.,M.R.C.P.
  • Chairman of the Board
  • 255.64K
  • Steven B. Binder
  • Director
  • 2.34M
  • Jennifer Grancio
  • Independent Director
  • 221.73K
  • Christine A. Mundkur
  • Independent Director
  • 226.73K
  • Ronald J. Consiglio
  • Independent Director
  • 241.73K
  • Anthony C. Hooper
  • Independent Director
  • 233.14K
  • Dr. Sabrina Kay, PhD
  • Independent Director
  • 221.73K
  • Dr. Michael A. Friedman M.D.
  • Independent Director
  • 229.23K
  • Dr. David B. Thon, J.D.,PhD
  • General Counsel and Secretary
  • 2.34M
Market Insights
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.